Variations in Hematologic Responses to Increased Lead Absorption in Young Children by Chisolm, J. Julian et al.
Environmental Health Perspectives
Variations in Hematologic Responses to
Increased lead Absorption
in Young Children
by 1. Julian Chisolm, Jr.,* E. David Mellits,t lulian E. Keil,'
and Maureen B. Barrettt
In the study of human populations, much emphasis is placed on the concentration of
lead in whole peripheral blood. There is a considerable body of evidence which indicates
that this measurement reflects recent and current assimilation of lead. While broad
ranges in blood lead concentration have been associated with differing risks of toxicity
for groups, it is not a precise index of adverse effect per se, even at elevated levels.
Within the red blood cell itself there is not a close association between the concentra-
tion of lead and such adverse metabolic effects as the increased loss of potassium caused
by lead. Above the apparent "threshold zone" of approximately 30-50 ,sg Pb/100 ml whole
blood, equivalent metabolic effects on heme synthesis may be seen over an interval of at
least 20 ,ug Pb/100 ml whole blood. This variation will be examined with particular refer-
ence to the interrelationship between the concentrations of lead and protoporphyrin in
peripheral blood. The data indicate that limitations in both precision and accuracy of
measurement account for a relatively small fraction of the observed variations. Together
with other experimental and clinical information, they suggest that concurrent dietary
deficiency of iron may be one of the important modifying factors in the responses of
subjects with increased lead absorption. It is suggested that suspected adverse effects
upon the various organ systems associated with increased lead absorption be measured
directly and that the CaEDTA mobilization test for lead should be more fully explored
as a measure of the "metabolically active" fraction of the total body lead burden.
Introduction
In the study of human populations, much
emphasis is placed on the concentration of
lead in whole peripheral blood (Lg Pb/100
ml whole blood). There is a considerable
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body of evidence which indicates that this
measurement reflects the level of recent and
current assimilation of lead (1). Followup
studies show that slight to moderate eleva-
tions are also found in individuals with a
history of "high dose" types of exposure in
the remote past (2). In short, the measure-
ment is affected by the balance among assim-
ilation, excretion, and storage, but strictly
speaking, it is not a measure of effect.
While broad ranges in blood lead concentra-
tion are associated with differing risks of
toxicity, studies in individuals make it clear
that this measurement is not a precise index
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els. Above the apparent "threshold zone" of
approximately 30-50 jg Pb (1), equivalent
metabolic effects on heme synthesis may be
seen over a span of at least 20,g Pb. Often-
and sometimes with good reason-the ap-
parent lack of close correlation between
blood lead concentration and various effects
is ascribed to imprecise laboratory data (3).
However, interpretations based on biologi-
cal and epidemiological variables also de-
serve careful consideration. For example,
within the red blood cell itself, there is no
close association between the total concen-
tration of lead and such adverse effects as
the increased loss of potassium caused by
lead (4, 5). There is also some experimental
evidence that certain nutritional deficiencies
(6, 7) may interact with lead and so modify
the effects observed. The interplay between
absorption and effect may be examined more
closely by using the interrelationship be-
tween the hematocrit and the concentrations
of lead and erythrocyte protoporphyrin
(PROTO) in peripheral blood as an example.
Methods and Materials
In late 1971, in collaboration with the Bu-
reau of Community Environmental Manage-
ment, HSMHA, DHEW, 115 presumably
well, preschool children from old housing
areas in Charleston, S.C. were tested. Hema-
tocrit and protoporphyrin were measured in
duplicate capillary blood samples. Venous
blood was drawn simultaneously for lead de-
termination. Protoporphyrin was measured
immediately by a one-step extraction tech-
nique, as described elsewhere (8). Lead was
measured in dilute perchloric acid filtrates
of whole blood by atomic absorption spectro-
photometry (AAS) at 283.3 nm, simultan-
eous deuterium background correction and
similarly treated normal human blood spiked
with lead being used as reference standL
ards to compensate for nonspecific matrix
effects (Chisolm and Harrison, in prepara-
tion). Standard statistical techniques, in-
cluding least-squares regression and analysis
of covariance, were used.
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FIGURE 1. Relationship between concentration of lead
and protoporphyrin in whole blood in preschool
children: (0) children with 30-35% hematrocrit;
(X) children with 36-42% hematocrit. Bands A
and B show precision limits for each type of mea-
surement (see text).
Results
The results of this study are shown in Fig-
ure 1. Although both lead and protoporphy-
rin are found almost exclusively in or on red
blood cells, the data are presented in terms
of their concentrations in whole blood, the
medium in which each was measured. For
the acidified acetone method used to assay
protoporphyrin, the "normal" value is 3.17
± 1.36 ug PROTO/100 ml whole blood or
7.58 ± 3.25 jug PROTO/100 ml red blood
cells for 38%o hematocrit. This normal value
is about one-seventh of the values found by
classical extraction methods for free erythro-
cyte protoporphyrin (FEP). It was deter-
mined in a separate group of 34 preschool
children who were carefully selected to ex-
clude anemia (hematocrit > 36%o) and even
minimal inhibitory effects of lead on heme
synthesis (whole blood lead concentrations
of < 30 jug Pb by two independent methods
of analysis). The mean for this group was
20.7 ± 5.4 jg Pb. The reliability of the
PROTO assay was determined in a separate
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FIGURE 2. Comparison of protoporphyrin values ob-
tained in 24 children on two successive days. For
each child, the first day's result is plotted on the
abscissa against the second day's result on the
ordinate. The diagonal line represents the line of
perfect positive correlation. For the actual data,
the slope of regression does not differ significantly
from 1, the intercept does not differ significantly
from 0 and r = 0.98.
group of 24 children in whom the assay was
repeated on successive days on coded sam-
ples. The first day's result is plotted against
the second day's result in Figure 2. The test
shows good day-to-day reproducibility in in-
dividual children. In Figure 1, a curvilinear
relationship between the concentrations of
lead and protoporphyrin in blood is appar-
ent. For the group as a whole, the relationship
between blood lead concentration and ln
[PROTO] is linear, statistically significant
(P < 0.001, r = 0.60) and is described by
the following equation: jg Pb = 22.30 +
(8.92 In [PROTO]) S.D. = 10.04,/.. Above
the apparent threshold zone of 30-50 jg Pb,
there is great variation in the response of
individuals as measured by PROTO. To il-
lustrate the portions of the observed differ-
ences attributed to limitations in the pre-
cision of the measurements, hatched areas A,
B, and C have been superimposed on Figure
1. Band B shows the range of difference be-
tween duplicate PROTO measurements (2.26
jug PROTO/100 ml whole blood) at a
concentration level which is just above the
normal range. Band A shows the 95% con-
fidence limits for the precision of the AAS
method for blood lead analysis and is super-
imposed at the 50 ,g Pb level. Area C rep-
resents the intersection of bands A and B
and shows the approximate 95%o confidence
limits for the measurements at the 50 ,Ag
Pb level. The "relative accuracy" of the lead
method was studied in a separate group of
113 children with blood lead levels in a com-
parable concentration range in whom ven-
ous samples were split for measurement by
both the AAS and a double extraction dithi-
zone technique. Least-squares regression
analysis indicates that the two methods give
comparable results (9). No significant pro-
portional error was found (slope = 1.022),
constant error was small (intercept = 2.0
,g Pb), but the random error using N-2 was
±3.7 ,,g Pb (SDy/.). Similarly, in split
samples of blood, it was found that the acidi-
fied acetone method gives values for protopor-
phyrin which in heparinized blood are one-
seventh of the values found with a double
extraction technique (8) for free erythro-
cyte protoporphyrin. It does not appear that
errors in measurement of the order of 10%o
account for the 400% to 800%b variations
found in PROTO in children with elevated
blood lead levels.
The 115 children in the group were divided
into two subgroups according to hematocrit:
40 had hematocrits of 30-35 and 75 had
hematocrits of 36-42%o. Least-squares re-
gression analysis revealed two separate, but
essentially parallel slopes in each subgroup
for the regression of blood lead concentra-
tion on protoporphyrin concentration (Fig.
3). Covariance analysis showed that these
regression lines differ significantly at the
0.01 probability level. Throughout the range
of blood lead concentration, those with 30-
35%o hematocrit show PROTO values which
are double the values found in the children
with 36-42% hematocrit. The data suggest
that mild degrees of anemia account for at
least a part of the differences in response
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FIGURE 3. Relationship between concentrations of
lead and protoporphyrin in whole blood according
to hematocrit subgroupings. Separate but essen-
tially parallel slopes which differ significantly at
the 0.01 probability level are found for normal and
slightly reduced hematocrit ranges in the regres-
sion of PROTO on blood lead concentration. For
the two groups, the equations are as follows: For
3642% (mean = 38.2%) hematocrit: ,ug Pb =
24.16 + (9.06 ln [PROTO] and S.D.y,/ = 9.82, N
= 75, r = 0.59, P<0.001, range of blood lead con-
centration = 19-81 ug Pb (m = 40.7,/ g Pb). For
30-35% (mean = 33.9%) hematocrit: ,ug Pb =
16.22 + (9.95 ln [PROTO] and S.D.,/. = 9.41,
N = 40, r = 0.70, P<0.001, range of blood lead
concentration = 19-71 ug Pb (m = 36.9 lAg Pb).
which were found in children with the
higher blood lead concentrations.
Discussion
These results confirm the reports of others
(10-12) who also found a curvilinear rela-
tionship between the concentrations of lead
and protoporphyrin in blood. This report ex-
tends these observations by pointing to an
interaction between lead absorption and mild
anemia. The variation in metabolic response
observed is not unique to this particular in-
terrelationship. The report of Selander and
Cramer (13) is representative of a number
of studies. They found a similar curvilinear
relationship between blood lead concentra-
tion and ALA excretion. At levels between
40 and 70 jg Pb, they found large differ-
ences in ALA excretion ranging between
normal and five times greater than normal.
Similarly, we have found in children that
there is a statistically significant semilogar-
ithmic relationship between blood lead con-
centration and the response to the CaEDTA
mobilization test; however, there is consid-
erable variation about the line of regres-
sion, even when timed quantitative 24-hr
urine collections are made (Chisolm, unpub-
lished data).
It is difficult to arrive at firm conclusions
on the basis of data obtained at a single
point in time, as was the data just presented.
The dynamic longitudinal aspect of the me-
tabolism of lead and variables in individuals
may not be evident. In addition, the clinician
deals with unknown and uncontrolled vari-
ables, rather than the "steady state" of the
experimentalist. Nevertheless, these data may
be interpreted in the light of other work and
at least to the extent of pointing out fruit-
ful directions for future inquiry. Among the
115 children whose data are shown in Figure
1, there were nine with borderline elevations
in protoporphyrin concentration (7-14 1tg
PROTO/100 ml whole blood) who had blood
lead concentrations of 51-65 jig Pb. None
were anemic (37-42%o hematocrit) and,
save one three-year-old, all were 4 or 5 years
of age. These discrepancies may reflect re-
cent large, but isolated ingestions of lead.
Precedent for this interpretation is found
in the balance studies of Kehoe (14) who
observed transient increases in blood lead
concentration of similar magnitude in asso-
ciation with transient increases in the ali-
mentary intake of lead. Similarly, recent
studies in baboons (15) suggest that single
large doses of lead may be cleared rapidly
from the blood. We now have serial meas-
urements in several children which are con-
sistent with this hypothesis; namely, stable
borderline increases in PROTO have been
observed in association with blood lead
concentrations which occasionally spike to
60-65 jg Pb from. a basel level of 35-45 ,g
Pb. Alternatively, since eight of the nine
children cited were 4 or 5 years of age, the
findings may represent the influence of the
slow excretion of excess boney stores of lead
resulting from prior increased intake, rather
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also precedent for this interpretation (2, 14,
16). Only serial measurements can aid in
choosing among these alternatives; however,
despite their elevated blood lead levels in the
51-65 jug Pb range, it is clear that these nine
children were not showing any obvious un-
toward hematologic effects: their hemato-
crits were normal and their PROTO values
fell just above the normal range. This may
be contrasted with protoporphyrin values
reported in children with manifest plumbism
which were 40-250 times normal levels (17).
There were 15 other children in this group
with blood lead concentrations in the 50-80
,fg Pb range in whom PROTO values ranged
between 5 and 45 times the normal values;
these are the ones showing the greater ad-
verse metabolic effect. Statistical treatment
of the data suggests that mild reduction in
hematocrit is a significant factor interacting
with lead in this group. Although more ex-
tensive hematologic data were not obtained,
epidemiologic considerations (18) and ex-
perimental data (1, 6) strongly implicate
iron deficiency as the factor most likely to
account for the marked difference in meta-
bolic effect observed. Data in adults suggest
that erythrocyte protoporphyrin is, perhaps,
the most sensitive index of both latent and
manifest iron deficiency (19).
In the inherently unsteady clinical situa-
tion in which intake of lead by children may
fluctuate widely in relation to variable resi-
dence and multiple caretakers, direct meas-
urements of various effects such as erythro-
cyte protoporphyrin may provide a valuable
index of subelinical effect as well as aver-
age assimilation over a period of time. It
would be of interest to know how closely
effects on heme synthesis are related to the
effects of lead in other target organs such
as the nervous system. In one pediatric
study in which subjects and controls were
separated on the basis of residence and co-
proporphyrinuria, measurable deficits were
found on followup in fine motor function
and behavior (20). It is entirely possible
that the subelinical effects of plumbism in
the nervous system and the hematopoietic
system may be more closely related to one
another than either is to infrequent measure-
ments of blood lead concentration which may
be acutely affected by sharp fluctuations in
assimilation. Concurrent anemia -ven of
mild degree-and quite possibly other fac-
tors should also be taken into account in
evaluating the effects of increased lead ab-
sorption.
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